Knee osteoarthritis

• Allogenic mesenchymal stem cell intraarticular injection for knee osteoarthritis therapy, an RCT explorative mode-of-action study Not authorised
  2023-506088-33-00 9
• Randomized control trial comparison between intra-articular infiltrations of PRP, MFAT, and PRP-MFAT in the treatment of symptomatic knee os … Pending
  2023-507683-40-00 5
• A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of PPV-06 Active Immunotherapy … Pending
  2024-514388-24-00 4
• Adductor canal and IPACK (infiltration between the popliteal artery and the capsule of the knee) blocks versus genicular nerves block for to … Pending
  2025-523071-34-00 6
• First-in-human study to assess the safety and feasibility of intra-articular administration of allogeneic engineered gingival fibroblasts (a … Pending
  2026-525604-99-00 1
• A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Intra-Articular Allocetra in Participants with Primary Knee … Recruiting
  2025-524668-39-00 4 2026-05-15
• LIPIOJOINT-2 : A randomized sham-controlled, double blind, multicenter trial on the effect of Genicular Arteries Embolization in symptomatic … Recruiting
  2023-508844-24-00 5 2024-09-30
• Adaptative, multicenter, randomized, double-blind, parallel-group, placebo controlled, clinical trial, on the efficacy and tolerability of d … Recruiting
  2024-511961-12-00 10 2023-10-12
• A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of KBP-336 as an Adjunct to Diet and Exercise in Ob … Recruitment ended
  2024-517264-27-00 4 2024-12-13
• A Study on Diclofenac vs. Placebo for Knee Osteoarthritis Recruitment ended
  2024-510757-95-01 6 2024-08-01
• Allogenic mesenchymal stem cell intraarticular injection for knee osteoarthritis therapy, an RCT explorative mode-of-action study Recruitment ended
  2023-506088-33-01 9 2024-03-07
• Phase III, multicentre, randomized, open clinical trial comparing treatment with allogenic mesenchymal cells against autologous mesenchymal … Recruitment ended
  2024-514545-11-00 5 2021-05-26
• A prospective, double-blinded, randomized, placebo-controlled phase 1/2a study to assess safety, tolerability, systemic exposure and prelimi … Ended
  2024-517920-21-00 9 2025-08-19
• The effects of 2-week long treatment with naproxen sodium (Nalgesin® Forte) on synovial fluid cytokine and naproxen concentration and clinic … Ended
  2023-505875-56-00 6 2025-05-21
• A Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Trial to Evaluate the Efficacy and Safety of Once Daily Diclofenac Gel AMZ001 … Ended
  2024-517404-11-00 5 2025-04-30
• A placebo-controlled, double-blinded, randomized, dose-finding trial using a combination of apocynin and paeonol (APPA) for the treatment of … Ended
  2023-508791-11-00 4 2024-07-08
• A Phase 1/2a Randomized, Double-Blind Placebo-controlled Study of Intra-articular Allocetra in Knee Osteoarthritis Ended
  2023-508748-23-00 9 2024-03-26
• A randomized, placebo controlled, investigator and participant-blinded study, investigating safety, tolerability and efficacy of RHH646 in p … Ended
  2022-502821-16-00 4 2023-09-01
• Safety, tolerability and pharmacokinetics of intra‐articular (IA) single ascending dose of 4P‐004 in patient with Kellgren and Lawrence grad … Ended
  2022-500271-31-00 3 2023-05-10
• A proof-of-concept study to examine QUC398 in participants with knee osteoarthritis Ended
  2023-509274-28-00 4 2023-02-03
• Study of efficacy, safety and tolerability of DFV890 in patients with knee osteoarthritis Ended
  2023-507559-30-00 4 2021-11-09

Showing 1–21 of 21 trials